Evidence map›Paper›PMID 33449936›Full record

Trial reportPloS one2021

Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function.

Jennifer A Hirst, José M Ordóñez Mena, Chris A O'Callaghan, Emma Ogburn, Clare J Taylor, Yaling Yang, F D Richard Hobbs

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Multimorbidity Management: A Scoping Review of Interventions and Health Outcomes.International journal of environmental research and public health · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

  • Commented on by
    2021
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jennifer A HirstNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.ORCID 0000-0002-8416-2159
José M Ordóñez MenaNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.
Chris A O'CallaghanNuffield Dept Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-9962-3248
Emma OgburnNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.
Clare J TaylorNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.
Yaling YangNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.
F D Richard HobbsNuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Oxford, United Kingdom.
National Institute for Health Research · GBUniversity of Oxford · GB

Funding

Department of Health
6 · The paper itself

Abstract

objectivesTo establish the prevalence of multimorbidity in people with chronic kidney disease (CKD) stages 1-5 and transiently impaired renal function and identify factors associated with multimorbidity. DESIGN AND

settingProspective cohort study in UK primary care.

participants861 participants aged 60 and older with decreased renal function of whom, 584 (65.8%) had CKD and 277 (32.2%) did not have CKD.

interventionsParticipants underwent medical history and clinical assessment, and blood and urine sampling. PRIMARY AND SECONDARY OUTCOME MEASURES: Multimorbidity was defined as presence of ≥2 chronic conditions including CKD. Prevalence of each condition, co-existing conditions and multimorbidity were described and logistic regression was used to identify predictors of multimorbidity.

resultsThe mean (±SD) age of participants was 74±7 years, 54% were women and 98% were white. After CKD, the next most prevalent condition was hypertension (n = 511, 59.3%), followed by obesity (n = 265, 30.8%) ischemic heart disease (n = 145, 16.8%) and diabetes (n = 133, 15.4%). Having two co-existing conditions was most common (27%), the most common combination of which was hypertension and obesity (29%). One or three conditions was the next most prevalent combination (20% and 21% respectively). The prevalence of multimorbidity was 73.9% (95%CI 70.9-76.8) in all participants and 86.6% (95%CI 83.9-89.3) in those with any-stage CKD. Logistic regression found a significant association between increasing age (OR 1.07, 95%CI 1.04-0.10), increasing BMI (OR 1.15, 95%CI 1.10-1.20) and decreasing eGFR (OR 0.99, 95%CI 0.98-1.00) with multimorbidity.

conclusionsThis analysis is the first to provide an accurate estimate of the prevalence of multimorbidity in a screened older primary care population living with or at risk of CKD across all stages. Hypertension and obesity were the most common combination of conditions other than CKD that people were living with, suggesting that there may be multiple reasons for closely monitoring health status in individuals with CKD.

Indexed as

MultimorbidityAgedAged, 80 and overDiabetic NephropathiesFemaleHumansHypertensionMaleObesityPrevalencePrimary Health CareProspective StudiesRenal Insufficiency, ChronicRisk Factors

Identifiers

PMID33449936
PMCPMC7810320
OpenAlexW3120209253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.